Treatment of type 1 diabetes (T1D) is entering a transformative era. The first immunotherapy approved to delay clinical onset—Teplizumab—has received FDA approval in the United S...
WHO Releases First GLP-1 Obesity Treatment Guideline, Signaling New Opportunities for the Global Pharma IndustryThe World Health Organization (WHO) has issued its first global guid...